Month: May 2026

Commentary

Clinical syndromes and molecular allergens: a clarification on the proposed “defensin syndrome”

/ by edra

Comment on “Clinical terminology and biological mediators in allergology: why biomarkers do not define a syndrome” – doi: 10.23822/EurAnnACI.1764-1489.437

Read more »

Letter to the Editor

Clinical terminology and biological mediators in allergology: why biomarkers do not define a syndrome

by edra

Read more »

Original Article

Impact of body composition on airway inflammation: analyzing FeNO z-scores in non-asthmatic school-aged children using GAMLSS modeling

/ by edra

Background. Obesity is associated with worse asthma outcomes, partly due to inflammasome-mediated neutrophilic Type IVc immunity. However, the impact of adiposity on Type IVb airway inflammation remains poorly understood. This study aimed to evaluate the effect of body fat on Type 2 (T2) airway inflammation, measured using fractional exhaled nitric oxide (FeNO). Methods. This community-based […]

Read more »

Letter to the Editor

Efficacy and safety of mepolizumab in hypereosinophilic syndrome

/ by edra

Read more »

Letter to the Editor

Long-term real-world effectiveness of Mepolizumab in EGPA: support for a step-up dosing strategy

/ by edra

Read more »

To top